- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mereo Biopharma Group plc
Headquarters: London, United Kingdom
Website: https://www.mereobiopharma.com...
Year Founded: 2004
Status: Public
Industry Sector: HealthTechnology
CEO: Denise Vera Scots-Knight, PhD
Number Of Employees: 33
Enterprise Value: $253,198,712
PE Ratio: -10.16
Exchange/Ticker 1: NASDAQ:MREO
Exchange/Ticker 2: N/A
Latest Market Cap: $393,024,416
BioCentury | Sep 1, 2023
Finance
Tier-jumpers: Building the road to sustainable biotechs. Back to School 2023
How companies can build value and climb market cap tiers to reach the top
BioCentury | Dec 1, 2021
Regulation
Nov. 30 Quick Takes: BeiGene’s $3.5B hat trick
Plus FDA panel narrowly backs molnupiravir and updates from Mana, Molecular Partners, Krystal, Mereo, Blueprint, AZ
BioCentury | Nov 2, 2021
Data Byte
The AATD pipeline
Clinical programs include proteins, RNAi and small molecules, with gene editing getting in the game too
BioCentury | May 1, 2021
Regulation
April 30 Quick Takes: Bilenker has $212M to build newco Treeline’s toolbox; plus Farxiga, Opdivo, BioCryst, Leo, Hikma and more
An SEC filing released Friday revealed that Josh Bilenker and Jeffrey Engelman have $212 million to begin building newly launched Treeline Biosciences Inc.’s toolbox for chasing validated but
BioCentury | Dec 18, 2020
Deals
Dec. 17 Quick Takes: Ultragenyx gains rights to Mereo’s setrusumab; plus Verily’s $700M raise, dMed’s listing plans, Virios’ IPO
Ultragenyx gains ex-Europe rights to Mereo’s setrusumabUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) licensed ex-European rights to setrusumab from Mereo BioPharma Group plc (LSE:MPH;
BioCentury | Oct 20, 2020
Management Tracks
J&J promotes Kumar; plus moves at Krystal, Design, Centogene, Lyndra, Mereo and Neoleukin
Johnson & Johnson (NYSE:JNJ) has promoted Seema Kumar to global head of the Office of Innovation, Global Health and Scientific Engagement from VP of innovation, global health and policy
BioCentury | Jul 3, 2020
Management Tracks
Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more
BioCentury | Jun 4, 2020
Finance
TIGIT program drives OrbiMed-led $70M raise as Mereo looks to Phase Ib
BioCentury | Dec 21, 2019
Company News
Management Tracks: Ionis promotes co-founder to CSO; Syros adds Celgene vet Alles to board; plus Encoded, Cygnal, Harvard Medical School, Immunitas and more
BioCentury | Dec 11, 2019
Company News
Management tracks: Elevate hires CSO of regenerative medicine; plus BridgeBio, Acceleron, Flexion, Locana, Nkarta and more
Items per page:
1 - 10 of 21